Literature DB >> 16218428

[Hypoadiponectinemia implies the development of atherosclerosis in carotid and coronary arteries].

Keisuke Shioji1, Akira Moriguchi, Soji Moriwaki, Kenichi Manabe, Yuzo Takeuchi, Takashi Uegaito, Satoru Mutsuo, Mitsuo Matsuda.   

Abstract

OBJECTIVES: Adiponectin is an adipocyte-derived endocrine factor. Hypoadiponectinemia has been observed in obese patients, and plasma adiponectin levels are reported to increase during weight reduction. Moreover, hypoadiponectinemia has also been observed in patients with coronary artery diseases. The present study investigated the relationships between levels of adiponectin and carotid intimal-medial thickness, a marker of early vascular disease, and carotid artery plaque and the severity of coronary artery disease, a marker of advanced vascular disease.
METHODS: Four hundred thirty-one consecutive patients were enrolled from inpatients without acute coronary syndrome who underwent coronary angiography between August 2001 and August 2003. The residual adiponectin levels were calculated by adjusting for sex, age, and body mass index, and a logarithmic transformation was applied. The severity of coronary artery disease was evaluated by coronary angiography and divided into four groups (Group 0: no significant organic stenosis, Group 1: 1-vessel disease, Group 2: 2-vessel disease, Group 3: 3-vessel disease or left main coronary trunk disease). Carotid plaque was evaluated by ultrasonography and divided into two groups [Group(-) : patients without carotid plaque, Group (+): patients with carotid plaque]. The intimal-medial thickness was measured on a longitudinal scan of the common carotid artery at a point 1 cm proximal from the bifurcation bulb.
RESULTS: The logarithmic-transformed levels of residual adiponectin were associated with severity of coronary artery disease (Group 0: 0.18 +/- 0.59 microg/ml, Group 1: -0.02 +/- 0.56 microg/ml, Group 2: - 0.09 +/- 0.58 microg/ml, Group 3: - 0.10 +/- 0.66 microg/ml, p = 0.0013). The logarithmic-transformed levels of residual adiponectin were decreased in patients with carotid plaque [Group (-): 0.08 +/- 0.59 microg/ml, Group (+): - 0.08 +/- 0.59 microg/ml, p = 0.045]. However, the logarithmic-transformed levels of residual adiponectin were not associated with intimal-medial thickness (p = 0.6398).
CONCLUSIONS: Hypoadiponectinemia adjusted for sex, age, body mass index implies the progression of carotid and coronary sclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16218428

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  4 in total

Review 1.  Epicardial adipose tissue: far more than a fat depot.

Authors:  Andrew H Talman; Peter J Psaltis; James D Cameron; Ian T Meredith; Sujith K Seneviratne; Dennis T L Wong
Journal:  Cardiovasc Diagn Ther       Date:  2014-12

Review 2.  Adiponectin, cardiovascular disease, chronic kidney disease: emerging data on complex interactions.

Authors:  Megan M Lo; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2011-02-21       Impact factor: 3.714

3.  Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.

Authors:  Zhuofeng Lin; Xuebo Pan; Fan Wu; Dewei Ye; Yi Zhang; Yu Wang; Leigang Jin; Qizhou Lian; Yu Huang; Hong Ding; Chris Triggle; Kai Wang; Xiaokun Li; Aimin Xu
Journal:  Circulation       Date:  2015-03-20       Impact factor: 29.690

Review 4.  Cardiac Obesity and Cardiac Cachexia: Is There a Pathophysiological Link?

Authors:  K Selthofer-Relatić; A Kibel; D Delić-Brkljačić; I Bošnjak
Journal:  J Obes       Date:  2019-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.